Tau Aggregation Inhibitors

The promise of tau aggregation inhibitors in dementia

The Phase III LUCIDITY trial: a tau aggregation inhibitor in patients with Alzheimer’s disease

SENS4 - Tau Aggregation Inhibitor Therapy For Neurodegenerative Disorders (1/2)

What is tau and what’s it got to do with Alzheimer’s?

AlzheimersResearch UK

SENS4 - Tau Aggregation Inhibitor Therapy For Neurodegenerative Disorders (1/2)

Research Highlight: Toxic tau aggregates determines type of dementia

UT Southwestern Medical Center

Targeting Tau in Alzheimer's Disease

TauRxTherapeutics

Methylation regulates Tau aggregation and neuronal health in Alzheimer’s disease

Research Square

Neurofibrillary tangles and Tau protein (Alzheimer)

Pharmacology Animation

Alzheimer's Disease: APP Processing & Amyloid Plaque Formation

NovusBiologicals

Aggregation Assays Using Hyperphosphorylated Tau Protein l Protocol Preview

JoVE (Journal of Visualized Experiments)

Mechanism of Alzheimer's Disease

Tau Protein Pathology in Alzheimer's Disease

TauRxTherapeutics

Tyrosine phosphorylation is key to preventing Tau tangles in neurodegenerative diseases

Research Square

Mutated Tau Proteins and Neurodegeneration

Johns Hopkins Medicine

Tau fibrils versus tau oligomers in neurotoxicity and neurodegeneration

APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD

University of California Television (UCTV)

Tau Therapies for Alzheimer's Disease

Alzheimer's Disease - The amyloid cascade, alternative mechanisms

Michigan Medicine

What causes Alzheimer's disease: Amyloid vs Tau